Advertisements


Pharma/Biotech Stocks to Watch This Prostate Cancer Month

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

The Daily Biotech Pulse: Gilead"s Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Oct. 26) read more.....»»

Category: blogSource: benzingaOct 26th, 2018

This tiny biotech spun a quick $2 billion from $12 million

Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»

Category: topSource: marketwatchOct 18th, 2018

Cannabis Watch: Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and more

Drugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants......»»

Category: topSource: marketwatchOct 16th, 2018

Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More

Four pharma/biotech companies are set to release earnings .....»»

Category: personnelSource: nytApr 30th, 2018

Metals Stocks: Gold hovers near 10-month high as investors watch trade talks, Fed minutes

Gold edges higher Wednesday as bulls look to build on a rally that lifted the yellow metal to its highest finish since April a day earlier......»»

Category: topSource: marketwatchFeb 20th, 2019

The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) Alector Inc (NASDAQ: ALEC) (IPOed early Febru.....»»

Category: earningsSource: benzingaFeb 20th, 2019

The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) read more.....»»

Category: blogSource: benzingaFeb 20th, 2019

Europe Markets: European stocks hold onto 4-month highs; Wirecard soars

European markets were mostly down on Monday, after last week’s highs, as investor continue to watch trade negotiations between the U.S. and China unfold.....»»

Category: topSource: marketwatchFeb 18th, 2019

Europe Markets: European stocks hover at 4-month highs on hopes for more trade progress; Wirecard surges

European markets were mostly down on Monday, after last week’s highs, as investor continue to watch trade negotiations between the U.S. and China unfold.....»»

Category: topSource: marketwatchFeb 18th, 2019

3 Top Biotech Stocks to Buy in February

Here's why Viking Therapeutics, Cambrex, and Sarepta Therapeutics are all solid biotech plays this month......»»

Category: topSource: foxnewsFeb 17th, 2019

The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr"s Reverse Split, Ironwood Starts Phase 1 Trial

Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs Wednesday. Down In The Dumps (Biotech stocks hitting 52-week lows on Jan. 23) read more.....»»

Category: blogSource: benzingaJan 24th, 2019

2 Biotech Stocks On Watch Early In The Week

2 Biotech Stocks On Watch Early In The Week.....»»

Category: topSource: seekingalphaJan 22nd, 2019

Market Snapshot: Stocks poised to open lower, snap 2-session rise

U.S. stock futures head lower on Thursday, putting the indexes in position to end a two-day rise as investors digest quarterly results and watch for impacts from a nearly one-month partial shutdown of the government......»»

Category: topSource: marketwatchJan 17th, 2019

The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks The following biotech stocks struck 52-week highs Jan. 9:  read more.....»»

Category: blogSource: benzingaJan 10th, 2019

The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 8) read more.....»»

Category: blogSource: benzingaJan 9th, 2019

Cancer stocks heat up after third big merger in the past month

The third multibillion-dollar bu.....»»

Category: topSource: marketwatchJan 7th, 2019

The Celgene Deal Shows How the Lines Between Biotech and Big Pharma Have Blurred

When it comes to the acquisition of cancer-treating upstarts, Bristol-Myers has been here before.....»»

Category: topSource: barronsJan 4th, 2019

3 of the Cheapest Drug Stocks You Can Buy in 2019

These biotech and pharma stocks are valued at or below eight times next year's profit projections......»»

Category: topSource: foxnewsDec 26th, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»

Category: earningsSource: benzingaDec 13th, 2018

Is Intec Pharma a Sleeping Blockbuster Play?

The developmental biotech offers high reward, but for high riskRelated Stocks: NTEC,.....»»

Category: blogSource: gurufocusDec 11th, 2018